| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37f4922dfb7777b019e504b885211b8e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-689
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
| filingDate |
1986-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b381619f8bae4a3e156308d32ffecf1f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dae150477b33c2c116e46840594adc31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4cc143e77274ea5168f5b2383be5c503 |
| publicationDate |
1987-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0243390-A1 |
| titleOfInvention |
MAMMAL PROTEIN WITH IMMUNOMODULATORY AND PREGNANCY ACTIVITY. |
| abstract |
New protein characterized in particular by the fact: that it is present in the serum of pregnant females and normally absent in males; that it is present in the serum of individuals developing an inflammatory reaction; that it migrates by electrophoresis with alpha2-macroglobulins; that it has a molecular mass, measured by filtration on polyacrylamide gel, of approximately 800,000 9E 50,000; and that its administration in vivo significantly prolongs the survival of allografts; antibodies to this protein; their preparation and their application in particular as a medicine |
| priorityDate |
1985-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |